Simulation Medical ApS
Credit rating
Company information
About Simulation Medical ApS
Simulation Medical ApS (CVR number: 37836044) is a company from SLAGELSE. The company recorded a gross profit of -1413.9 kDKK in 2023. The operating profit was 599.4 kDKK, while net earnings were 522.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 11 %, which can be considered good and Return on Equity (ROE) was 9.2 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at -5.3 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Simulation Medical ApS's liquidity measured by quick ratio was 0.8 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 361.55 | 2 498.95 | -1 412.35 | - 189.75 | -1 413.90 |
EBIT | -55.78 | 483.54 | -1 412.35 | - 191.09 | 599.43 |
Net earnings | 66.73 | 392.25 | -1 124.86 | - 179.46 | 522.29 |
Shareholders equity total | 264.79 | 657.04 | - 574.82 | - 754.28 | - 231.99 |
Balance sheet total (assets) | 4 431.64 | 5 596.76 | 6 756.68 | 7 244.08 | 4 159.58 |
Net debt | 1 637.99 | 4 080.00 | 4 087.26 | 2 214.64 | 314.39 |
Profitability | |||||
EBIT-% | |||||
ROA | 4.2 % | 10.8 % | -22.0 % | -2.0 % | 11.0 % |
ROE | 28.8 % | 85.1 % | -30.3 % | -2.6 % | 9.2 % |
ROI | 8.6 % | 15.8 % | -30.9 % | -3.9 % | 29.3 % |
Economic value added (EVA) | -19.26 | 369.20 | -1 132.48 | - 111.86 | 601.75 |
Solvency | |||||
Equity ratio | 6.0 % | 11.7 % | -7.8 % | -9.4 % | -5.3 % |
Gearing | 648.4 % | 643.6 % | -752.2 % | -483.6 % | -430.1 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.7 | 1.5 | 1.1 | 1.1 | 0.8 |
Current ratio | 0.7 | 1.5 | 1.1 | 1.1 | 0.8 |
Cash and cash equivalents | 78.80 | 148.49 | 236.34 | 1 433.04 | 683.47 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BB | BB | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.